Mycobacterium tuberculosis infection in health care workers in rural India: Comparison of a whole-blood interferon γ assay with tuberculin skin testing

JAMA

Volumn 293, Issue 22, 2005, Pages 2746-2755

  Pai, Madhukar ^a,b   Gokhale, Kaustubh ^a   Joshi, Rajnish ^a   Dogra, Sandeep ^a   Kalantri, Shriprakash ^a   Mendiratta, Deepak K ^a   Narang, Pratibha ^a   Daley, Charles L ^c,e,f   Granich, Reuben M ^d,e,g   Mazurek, Gerald H ^d   Reingold, Arthur L ^b   Riley, Lee W ^b   Colford, John M ^b  

^a MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^g US President's Emergency Plan for AIDS Relief   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCG VACCINE; GAMMA INTERFERON; PROTEIN; PROTEIN 10; TUBERCULIN; TUBERCULOSIS ANTIGEN TB 7.7; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INDIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL SCHOOL; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; SAMPLE SIZE; SCAR; STATISTICAL SIGNIFICANCE; TUBERCULIN TEST; TUBERCULOSIS; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PHYSIOLOGY; RURAL POPULATION; VIRUS LATENCY;

ADULT; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HEALTH PERSONNEL; HUMANS; INDIA; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTORS; RURAL POPULATION; TUBERCULIN TEST; TUBERCULOSIS; VIRUS LATENCY;

EID: 20144372409     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.293.22.2746     Document Type: Article

References (44)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country: WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677-686.
2. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968-975.
3. Chadha VK. Tuberculin test. Indian J Pediatr. 2001;68:53-58.
4. Menzies RI. Tuberculin skin testing. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. New York, NY: Marcel Dekker; 2000:279-322.
5. Rieder HL. Epidemiologic Basis of Tuberculosis Control. Paris, France: International Union Against Tuberculosis and Lung Disease; 1999.
6. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356:1099-1104.
7. Lalvani A. Spotting latent infection: the path to better tuberculosis control. Thorax. 2003;58:916-918.
8. Pai M, Riley LW, Colford JM. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:761-776.
9. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52(RR-2):15-18.
10. Chadha VK. Epidemiological situation of tuberculosis in India. J Indian Med Assoc. 2003;101:144-147.
11. Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med. 2002;347:1420-1425.
12. Chadha VK, Kumar P, Jagannatha PS, Vaidyanathan PS, Unnikrishnan KP. Average annual risk of tuberculous infection in India. Int J Tuberc Lung Dis. 2005;9:116-118.
13. World Health Organization. Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings. Geneva, Switzerland: World Health Organization; 1999.
14. Rao KG, Aggarwal AN, Behera D. Tuberculosis among physicians in training. Int J Tuberc Lung Dis. 2004;8:1392-1394.
15. Gopinath KG, Siddique S, Kirubakaran H, Shanmugam A, Mathai E, Chandy GM. Tuberculosis among healthcare workers in a tertiary-care hospital in South India. J Hosp Infect. 2004;57:339-342.
16. Granich R, Chauhan LS. Status report of the Revised National Tuberculosis Control Programme: January 2003. J Indian Med Assoc. 2003;101:150-151, 156.
17. Narang P, Tyagi NK, Mendiratta DK, Jajoo UN, Bharambhe MS, Nayar S. Prevalence of sputumpositive pulmonary tuberculosis in tribal and nontribal populations of the Ashti and Karanja tahsils in Wardha district, Maharashtra State, India. Int J Tuberc Lung Dis. 1999;3:478-482.
18. Chadha VK, Jagannatha PS, Narang P, Savanur SJ, Mendiratta DK, Lakshminarayana . Annual risk of tuberculous infection in three districts of Maharashtra. Indian J Tuberc. 2003;50:125-132.
19. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221-S247.
20. Revised National Tuberculosis Control Programme. Technical Guidelines for Tuberculosis Control. New Delhi, India: Central TB Division, Directorate General of Health Services; 1997.
21. Chadha VK, Jagannatha PS, Vaidyanathan PS, Jagota P. PPD RT23 for tuberculin surveys in India. Int J Tuberc Lung Dis. 2003;7:172-179.
22. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004;170:65-69.
23. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004;170:59-64.
24. Hosmer D, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 2000.
25. Alonso-Echanove J, Granich RM, Laszlo A, et al. Occupational transmission of Mycobacterium tuberculosis to health care workers in a university hospital in Lima, Peru. Clin Infect Dis. 2001;33:589-596.
26. Do AN, Limpakarnjarat K, Uthaivoravit W, et al. Increased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand. Int J Tuberc Lung Dis. 1999;3:377-381.
27. Kassim S, Zuber P, Wiktor SZ, et al. Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis. 2000;4:321-326.
28. Menzies D, Fanning A, Yuan L, FitzGerald JM. Factors associated with tuberculin conversion in Canadian microbiology and pathology workers. Am J Respir Crit Care Med. 2003;167:599-602.
29. Sepkowitz KA. Tuberculin skin testing and the health care worker: lessons of the Prophit Survey. Tuber Lung Dis. 1996;77:81-85.
30. Arend SM, van Meijgaarden KE, de Boer K, et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M kansasii. J Infect Dis. 2002;186:1797-1807.
31. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168-1173.
32. Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis. 2004;38:966-973.
33. Richeldi L, Ewer K, Losi M, et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med. 2004;170:288-295.
34. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis. 2001;183:469-477.
35. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon-γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA. 2001;286:1740-1747.
36. Chadha VK, Jagannatha PS, HV S. Tuberculin sensitivity in BCG vaccinated children and its implication for ARI estimation. Indian J Tuberc. 2000;47:139-146.
37. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804-809.
38. Chadha VK, Jaganath PS, Kumar P. Tuberculin sensitivity among children vaccinated with BCG under universal immunization programme. Indian J Pediatr. 2004;71:1063-1068.
39. Chadha VK, Jagannatha PS, Kumar P. Can BCG-vaccinated children be included in tuberculin surveys to estimate the annual risk of tuberculous infection in India? Int J Tuberc Lung Dis. 2004;8:1437-1442.
40. Chakraborty AK, Ganapathy KT, Nair SS, Bhushan K. Prevalence of non-specific sensitivity of tuberculin in a South Indian rural population. Indian J Med Res. 1976;64:639-651.
41. Geluk A, van Meijgaarden KE, Franken KL, et al. Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell crossreactivity with Mycobacterium tuberculosis. Infect Immun. 2002;70:2544-2548.
42. Radhakrishna S, Frieden TR, Subramani R. Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in south India: a 15-year follow-up. Int J Tuberc Lung Dis. 2003;7:1083-1091.
43. Watkins RE, Brennan R, Plant AJ. Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis. 2000;4:895-903.
44. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosisspecific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002;40:704-706.